GeoVax Labs Inc (GOVX)

[WOLDUMAR]

GeoVax's Chief Scientific Officer to Speak at World Vaccine Congress
ATLANTA, GA--(NewMediaWire - Mar 31, 2015) - GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing innovative human vaccines for Ebola and HIV using its novel platform technology, today announced that Chief Scientific Officer Dr. Harriet L. Robinson, is invited to speak at the World Vaccine Congress to be held April 7-9, 2015 in Washington, DC. Dr. Robinson is scheduled to speak on April 8, 2015. The title of her talk is "Phase 2 Development of a Prophylactic HIV Vaccine."
The annual World Vaccine Congress, now in its 15th year, provides attendees with the opportunity to hear from leading government stakeholders, business leaders and scientific stakeholders as they continue to enhance the scientific and strategic innovation behind the vaccine industry. To find out more about the World Vaccine Congress event, visit:
http://www.terrapinn.com/conference/world-vaccine-congress-washington/index.stm